Trial Profile
Efficacy and safety of denosumab in treatment of hypercalcaemia in patients with solid tumour or haematologic malignancy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Hypercalcaemia
- Focus Therapeutic Use
- 13 Jun 2014 New trial record